Observational studyBMC infectious diseases2019

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir.

Eva Agnes Odongpiny Laker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.